Dofetilide In Structural Heart Disease Overview Dofetilide, a class III antiarrhythmic drug, is approved for managing atrial fibrillation and atrial flutter, but it has also been used off-label to treat premature ventricular complexes (PVCs) and ventricular tachycardias (VTs). This study aimed to assess the efficacy and safety of dofetilide for
Tag: Ventricular tachycardia
Stellate Ganglion Block Success In Recurrent Ventricular Arrhythmias
Stellate Ganglion Block Success In Recurrent Ventricular Arrhythmias Overview One potential treatment for refractory ventricular arrhythmias is a stellate ganglion block (SGB). This study analyzed the effectiveness of SGB based on patient and arrhythmia characteristics, as well as predictors of success. Conducted across multiple centers in the Czech Republic and the United
